Skip to main content
Clinical Trials/NCT02638818
NCT02638818
Completed
N/A

A Pilot Study Evaluating Health-related Quality of Life Endpoints in Patients Undergoing Minimally Invasive Versus Open Pancreaticoduodenectomy

Duke University0 sites57 target enrollmentJuly 25, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pancreatic Disease
Sponsor
Duke University
Enrollment
57
Primary Endpoint
Change in quality of life, as measured by FACT-Hep score
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the impact of the quality of life in patients undergoing the Whipple procedure (pancreaticoduodenectomy, PD) for pancreatic cancer. The Whipple procedure can be done by laparoscopic (small incisions) or an open procedure (large incision) to treat the patients cancer. The goal of this study is to see if there is any difference in quality of life between patients who undergo the laparoscopic or the open Whipple procedure. Surgical technique (minimally invasive versus open) will be at the discretion of the operating surgeon. Patients will not be randomized to a treatment arm.

A subset of these patients will also be asked to take part in a pre- and postoperative in-depth interview to explore the lived experiences of patients with resectable pancreatic cancer.

Registry
clinicaltrials.gov
Start Date
July 25, 2016
End Date
September 10, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients scheduled for pancreaticoduodenectomy will be eligible for this study.
  • Subject must be at least 18 years of age and at least the minimum Age of Majority according to applicable State or Country Law.
  • Subject is a suitable surgical candidate, i.e. is able to undergo general anesthesia and PD for diagnosis of cancer
  • Subject is willing and able to cooperate with survey participation.
  • Subject has been informed of the study procedures and the treatment and has signed an informed consent form

Exclusion Criteria

  • Subject is not a suitable candidate for PD

Outcomes

Primary Outcomes

Change in quality of life, as measured by FACT-Hep score

Time Frame: Baseline (before surgery), at hospital discharge (up to approximately 14 days), at first clinic visit (within 2 weeks after discharge), 3 months

The summed overall FACT-Hep score (0-180) will be the primary outcome.

Similar Trials